Pages that link to "Q81195427"
Jump to navigation
Jump to search
The following pages link to Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence (Q81195427):
Displaying 50 items.
- Management of low-grade squamous intra-epithelial lesions of the uterine cervix: repeat cytology versus immediate referral to colposcopy (Q24198130) (← links)
- Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions (Q24198236) (← links)
- Triage with human papillomavirus (HPV) testing versus repeat cytology for underlying high-grade cervical intra-epithelial neoplasia in women with minor cytological lesions (Q24240789) (← links)
- Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis (Q24647649) (← links)
- HPV-Testing in Follow-up of Patients Treated for CIN2 Lesions (Q26771420) (← links)
- Colposcopic triage methods for detecting cervical intraepithelial neoplasia grade 3 after cytopathological diagnosis of low-grade squamous intraepithelial lesion: a systematic review on diagnostic tests (Q26863434) (← links)
- Human Papillomavirus and Cervical Cancer: Biomarkers for Improved Prevention Efforts (Q27023127) (← links)
- E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective (Q28087374) (← links)
- Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test. (Q30238772) (← links)
- PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia (Q33318598) (← links)
- Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa (Q33619797) (← links)
- Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification. (Q33963645) (← links)
- Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology (Q34019808) (← links)
- HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy (Q34048160) (← links)
- High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysis (Q34135249) (← links)
- Colposcopic management of abnormal cervical cytology and histology (Q34508821) (← links)
- Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis (Q34913072) (← links)
- Quantitative survey of multiple CpGs from 5 genes identifies CpG methylation panel discriminating between high- and low-grade cervical intraepithelial neoplasia (Q35101902) (← links)
- Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection (Q35145250) (← links)
- HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study (Q35262983) (← links)
- Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma (Q35605623) (← links)
- Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix (Q35867881) (← links)
- Long‐term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment (Q35907158) (← links)
- HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice (Q36071760) (← links)
- Laboratory and clinical aspects of human papillomavirus testing (Q36311573) (← links)
- Identification of women for referral to colposcopy by neural networks: a preliminary study based on LBC and molecular biomarkers (Q36315991) (← links)
- Clinical utility of HPV genotyping (Q36578289) (← links)
- Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses (Q36584432) (← links)
- Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens (Q36608039) (← links)
- Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies (Q36644814) (← links)
- Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management (Q36739942) (← links)
- Primary extraosseous Ewing sarcoma of the lung in children (Q36791086) (← links)
- Cervical cancer prevention--cervical screening: science in evolution (Q37025863) (← links)
- Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention (Q37066141) (← links)
- Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings (Q37226899) (← links)
- Human papillomavirus infection and the primary and secondary prevention of cervical cancer. (Q37271947) (← links)
- Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions (Q37287526) (← links)
- Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries (Q37291430) (← links)
- Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate (Q37294687) (← links)
- Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types (Q37295681) (← links)
- Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening (Q37302153) (← links)
- Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer (Q37398007) (← links)
- p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis (Q37406427) (← links)
- Microarray detection of human papilloma virus genotypes among Turkish women with abnormal cytology at a colposcopy unit (Q37437302) (← links)
- Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections (Q37467424) (← links)
- How to evaluate emerging technologies in cervical cancer screening? (Q37467429) (← links)
- History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results (Q37570873) (← links)
- Evaluation of the Oncogenic Human Papillomavirus DNA Test with Liquid-Based Cytology in Primary Cervical Cancer Screening and the Importance of the ASC/SIL Ratio: A Belgian Study. (Q37622268) (← links)
- An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection (Q37725467) (← links)
- Can HPV testing replace the pap smear? (Q37788741) (← links)